JOHN W. CHILDS - 03 Feb 2026 Form 4 Insider Report for Veradermics, Inc (MANE)

Role
Director
Signature
/s/ Michael Greco, Attorney-in-Fact
Issuer symbol
MANE
Transactions as of
03 Feb 2026
Net transactions value
+$4,999,989
Form type
4
Filing time
05 Feb 2026, 19:04:00 UTC
Previous filing
17 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CHILDS JOHN W Director C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN /s/ Michael Greco, Attorney-in-Fact 05 Feb 2026 0001027035
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MANE Common Stock Conversion of derivative security +480,269 480,269 05 Feb 2026 See Footnote F1, F2
transaction MANE Common Stock Conversion of derivative security +906,862 +189% 1,387,131 05 Feb 2026 See Footnote F2, F3
transaction MANE Common Stock Conversion of derivative security +520,758 +38% 1,907,889 05 Feb 2026 See Footnote F2, F4
transaction MANE Common Stock Purchase $4,999,989 +294,117 +15% $17.00 2,202,006 05 Feb 2026 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MANE Series A Convertible Preferred Stock Conversion of derivative security -480,269 -100% 0 05 Feb 2026 Common Stock 480,269 See Footnote F1, F2
transaction MANE Series B Convertible Preferred Stock Conversion of derivative security -906,862 -100% 0 05 Feb 2026 Common Stock 906,862 See Footnote F2, F3
transaction MANE Series C Convertible Preferred Stock Conversion of derivative security -520,758 -100% 0 05 Feb 2026 Common Stock 520,758 See Footnote F2, F4
transaction MANE Stock Option (Right to Buy) Award $0 +51,525 $0.000000 51,525 03 Feb 2026 Common Stock 51,525 $17.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
F2 Shares held by J.W. Childs Associates (FL), L.P. John W. Childs 2013 Revocable Trust is the sole owner of J.W. Childs Associates (FL), L.P. The Reporting Person, a member of the board of directors of the Issuer, is Trustee of John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities.
F3 On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
F4 On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
F5 This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.